longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BYHEALTH

300146

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 24.28, within the reasonable range, cheaper than 52.11% of the time in the past 3 years, and the industry ranks 7/27, the industry Median 24.53.

24.28xP/E
¥9.31Stock price
¥0.38Earnings per share
24.28xP/E
Stock price¥9.31Earnings per share¥0.38

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
24.68x
Typical range
16.96x–31.07x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 24.53x
019385776

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 24.53x
0x20x40x60x80x100x
P/E ratio
Name/Symbol
300146SZBYHEALTH
24.28x9.67%¥15.75B
300957SZBTN
25.33x24.99%¥13.95B
603868SHFLYCO
24.53x19.07%¥13.50B
603193SHRunben Biotechnology
23.19x19.23%¥8.16B
605009SHHaoyue Care
22.53x21.30%¥5.35B
001328SZDencare
26.46x19.36%¥5.22B
603059SHPerfect
21.58x25.44%¥2.58B
603102SHBiohigh
20.23x--¥2.40B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.